Related references
Note: Only part of the references are listed.Matrix Metalloproteinase Inhibition With Doxycycline Affects the Progression of Posttraumatic Osteoarthritis After Anterior Cruciate Ligament Rupture: Evaluation in a New Nonsurgical Murine ACL Rupture Model
Xueying Zhang et al.
AMERICAN JOURNAL OF SPORTS MEDICINE (2020)
Identification of the targeted therapeutic potential of doxycycline for a subset of gastric cancer patients
Jaishree Pandian et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2020)
Development of oncolytic virotherapy: from genetic modification to combination therapy
Lan Qiaoshuai et al.
FRONTIERS OF MEDICINE (2020)
Oncolytic virotherapy armed with an engineered interfering lncRNA exhibits antitumor activity by blocking the epithelial mesenchymal transition in triple-negative breast cancer
Lin Ang et al.
CANCER LETTERS (2020)
Enhancing the antitumor activity of an engineered TRAIL-coated oncolytic adenovirus for treating acute myeloid leukemia
Zixuan Wang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
A Bicistronic Adenoviral Vector Carrying Cytosine Deaminase and Granulocyte-Macrophage Colony-Stimulating Factor Increases the Therapeutic Efficacy of Cancer Gene Therapy
Hakan Akbulut et al.
HUMAN GENE THERAPY (2019)
Defining a murine ovarian cancer model for the evaluation of conditionally-replicative adenovirus (CRAd) virotherapy agents
Rebeca Gonzalez-Pastor et al.
JOURNAL OF OVARIAN RESEARCH (2019)
Combination immunotherapy with IL-4 Pseudomonas exotoxin and IFN-α and IFN-γ mediate antitumor effects in vitro and in a mouse model of human ovarian cancer
Daniel S. Green et al.
IMMUNOTHERAPY (2019)
Abscopal effect when combining oncolytic adenovirus and checkpoint inhibitor in a humanized NOG mouse model of melanoma
Lukasz Kuryk et al.
JOURNAL OF MEDICAL VIROLOGY (2019)
Menstrual Blood-Derived Stem Cells as Delivery Vehicles for Oncolytic Adenovirus Virotherapy for Colorectal Cancer
Yang Guo et al.
STEM CELLS AND DEVELOPMENT (2019)
Advances in Targeted Gene Delivery
Anjuman A. Begum et al.
CURRENT DRUG DELIVERY (2019)
Doxycycline, salinomycin, monensin and ivermectin repositioned as cancer drugs
Anna Markowska et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Mesenchymal Stem Cell-Mediated Delivery of an Oncolytic Adenovirus Enhances Antitumor Efficacy in Hepatocellular Carcinoma
A-Rum Yoon et al.
CANCER RESEARCH (2019)
Systemic administration of human mesenchymal stromal cells infected with polymer-coated oncolytic adenovirus induces efficient pancreatic tumor homing and infiltration
Youjin Na et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Oncolytic adenovirus drives specific immune response generated by a poly-epitope pDNA vaccine encoding melanoma neoantigens into the tumor site
Alessandra Lopes et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Oncolytic adenovirus programmed by synthetic gene circuit for cancer immunotherapy
Huiya Huang et al.
NATURE COMMUNICATIONS (2019)
Vectors for Glioblastoma Gene Therapy: Viral & Non-Viral Delivery Strategies
Breanne Caffery et al.
NANOMATERIALS (2019)
Recent advances in the development of gene delivery systems
Y. K. Sung et al.
BIOMATERIALS RESEARCH (2019)
A prospective longitudinal evaluation of cognition and depression in postoperative patients with high-grade glioma following radiotherapy and chemotherapy
Qiang Wang et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2018)
The multiforme of glioblastoma
Farshad Nassiri et al.
NEURO-ONCOLOGY (2018)
A hypoxia- and telomeraseresponsive oncolytic adenovirus expressing secretable trimeric TRAIL triggers tumour-specific apoptosis and promotes viral dispersion in TRAIL-resistant glioblastoma
Eonju Oh et al.
SCIENTIFIC REPORTS (2018)
Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas
Qing Zhang et al.
STEM CELL RESEARCH & THERAPY (2018)
Tropism of mesenchymal stem cell toward CD133(+) stem cell of glioblastoma in vitro and promote tumor proliferation in vivo
Lorena Favaro Pavon et al.
STEM CELL RESEARCH & THERAPY (2018)
Combination therapy with F5/35 fiber chimeric conditionally replicative adenoviruses expressing IL-24 enhances the antitumor effect of temozolomide against melanoma
Ming Yang et al.
CANCER MEDICINE (2018)
The emerging role of oncolytic virus therapy against cancer
Luke Russell et al.
CHINESE CLINICAL ONCOLOGY (2018)
Human mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts
Simone Pacioni et al.
STEM CELL RESEARCH & THERAPY (2017)
Doxycycline Attenuates Leptospira-Induced IL-1β by Suppressing NLRP3 Inflammasome Priming
Wenlong Zhang et al.
FRONTIERS IN IMMUNOLOGY (2017)
Recombinant human endostatin combined with radiotherapy inhibits colorectal cancer growth
Ke Zhang et al.
BMC CANCER (2017)
A novel fiber chimeric conditionally replicative adenovirus-Ad5/F35 for tumor therapy
Ming Yang et al.
CANCER BIOLOGY & THERAPY (2017)
Application of conditionally replicating adenoviruses in tumor early diagnosis technology, gene-radiation therapy and chemotherapy
Shun Li et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2016)
Oncolytic virus therapy: A new era of cancer treatment at dawn
Hiroshi Fukuhara et al.
CANCER SCIENCE (2016)
Nanotechnology for mesenchymal stem cell therapies
Bruna Corradetti et al.
JOURNAL OF CONTROLLED RELEASE (2016)
A novel adenoviral vector carrying an all-in-one Tet-On system with an autoregulatory loop for tight, inducible transgene expression
Hao Chen et al.
BMC BIOTECHNOLOGY (2015)
Synergistic effects of co-administration of suicide gene expressing mesenchymal stem cells and prodrug-encapsulated liposome on aggressive lung melanoma metastases in mice
Tian-Yuan Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2015)
An armed, YB-1-dependent oncolytic adenovirus as a candidate for a combinatorial anti-glioma approach of virotherapy, suicide gene therapy and chemotherapeutic treatment
Y. Kostova et al.
CANCER GENE THERAPY (2015)
Potent antitumor activity of the Ad5/11 chimeric oncolytic adenovirus combined with interleukin-24 for acute myeloid leukemia via induction of apoptosis
Xubin Wei et al.
ONCOLOGY REPORTS (2015)
Adenoviral vector-mediated gene therapy for gliomas: coming of age
Maria G. Castro et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2014)
A Fiber Chimeric CRAd Vector Ad5/11-D24 Double-Armed with TRAIL and Arresten for Enhanced Glioblastoma Therapy
Xing Li et al.
HUMAN GENE THERAPY (2012)
Survival of European patients with central nervous system tumors
Milena Sant et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Mesenchymal stem cells as carriers and amplifiers in CRAd delivery to tumors
Xi Xia et al.
MOLECULAR CANCER (2011)
Tetracycline-inducible promoter-based conditionally replicative adenoviruses for the control of viral replication
H. Zhang et al.
CANCER GENE THERAPY (2009)
Human Bone Marrow-Derived Mesenchymal Stem Cells for Intravascular Delivery of Oncolytic Adenovirus Delta 24-RGD to Human Gliomas
Raymund L. Yong et al.
CANCER RESEARCH (2009)
Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy
Laura S. Sasportas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Improved gtioblastoma treatment with Ad5/35 fiber chimeric conditionally replicating adenoviruses
Dennis Hoffmann et al.
JOURNAL OF GENE MEDICINE (2007)
A bidirectional Tet-dependent promotor construct regulating the expression of EIA for tight control of oncolytic adenovirus replication
Henry Fechner et al.
JOURNAL OF BIOTECHNOLOGY (2007)
Endowing human adenovirus serotype 5 vectors with fiber domains of species B greatly enhances gene transfer into human mesenchymal stem cells
S Knaän-Shanzer et al.
STEM CELLS (2005)
Adenovirus structure
JJ Rux et al.
HUMAN GENE THERAPY (2004)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Adenovirus-mediated lymphotactin gene transfer improves therapeutic efficacy of cytosine deaminase suicide gene therapy in established murine colon carcinoma
DW Ju et al.
GENE THERAPY (2000)
Share Paper
